Purple Biotech Ltd (KTOV) — Cash Flow-to-Debt Ratio
Purple Biotech Ltd (KTOV) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2020, meaning its operating cash flow of ILA-2.32 Million could theoretically repay 0% of its total liabilities (ILA29.64 Million) in one year. See Purple Biotech Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Purple Biotech Ltd Cash Flow-to-Debt Ratio (2013–2019)
Historical debt coverage capacity for Purple Biotech Ltd across 7 annual periods. Also explore KTOV shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Purple Biotech Ltd (2013–2019)
Year-by-year debt coverage analysis for Purple Biotech Ltd. For market capitalisation and broader financial context, see KTOV stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2019 | -1.45x | ILA-5.58 Million | ILA3.86 Million | ▲ +36.6% |
| 2018 | -2.28x | ILA-8.48 Million | ILA3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | ILA-8.63 Million | ILA5.59 Million | ▲ +62.3% |
| 2016 | -4.10x | ILA-6.26 Million | ILA1.53 Million | ▼ -71.2% |
| 2015 | -2.39x | ILA-3.31 Million | ILA1.38 Million | ▲ +52.0% |
| 2014 | -4.98x | ILA-4.53 Million | ILA908.00K | ▼ -1123.8% |
| 2013 | -0.41x | ILA-512.00K | ILA1.26 Million | — |